# Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes

> **NCT02236481** · PHASE4 · TERMINATED · sponsor: **Prof. Roberto Giacomelli** · enrollment: 41 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Anakinra
- **DRUG:** TNF alpha inhibitors

## Key facts

- **NCT ID:** NCT02236481
- **Lead sponsor:** Prof. Roberto Giacomelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Decision of the Sponsor for Early Benefits
- **Last updated:** 2018-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02236481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02236481, "Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02236481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*